The importance of identifying this rare tumor is in view of its relatively favorable prognosis, unlike a spindle cell/sclerosing RMS that invariably shows an aggressive clinical course, in adult patients, especially those displaying the MYOD1 (L122R) mutation (3,7,8,12). The gene discussed is MYOD1; the disease is neoplasm.